about
The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study.The CRHR1 gene, trauma exposure, and alcoholism risk: a test of G × E effects.The relationship between methamphetamine and alcohol use in a community sample of methamphetamine users.Subjective response to alcohol and associated craving in heavy drinkers vs. alcohol dependents: an examination of Koob's allostatic model in humans.Development of the Neuroimmune Modulator Ibudilast for the Treatment of Alcoholism: A Randomized, Placebo-Controlled, Human Laboratory Trial.Modeling naturalistic craving, withdrawal, and affect during early nicotine abstinence: A pilot ecological momentary assessment study.Emotion differentiation and intensity during acute tobacco abstinence: A comparison of heavy and light smokers.Combined varenicline and naltrexone treatment reduces smoking topography intensity in heavy-drinking smokers.Factor Structure of Subjective Responses to Alcohol in Light and Heavy Drinkers.Genetic and Environmental Predictors of Alcohol Use in Asian American Young AdultsSubjective response to alcohol among alcohol-dependent individuals: effects of the μ-opioid receptor (OPRM1) gene and alcoholism severityDelta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol.Understanding naltrexone mechanism of action and pharmacogenetics in Asian Americans via behavioral economics: a preliminary study.Interactive effects of OPRM1 and DAT1 genetic variation on subjective responses to alcohol.Subjective Response to Alcohol as a Research Domain Criterion.Experimental psychopathology paradigms for alcohol use disorders: Applications for translational researchRelationship between negative affect and smoking topography in heavy drinking smokers.Naltrexone moderates the relationship between cue-induced craving and subjective response to methamphetamine in individuals with methamphetamine use disorder.Impulsivity Moderates Subjective Responses to Alcohol in Alcohol-Dependent Individuals.Negative affect is associated with alcohol, but not cigarette use in heavy drinking smokers.Predictors of smoking lapse in a human laboratory paradigm.Pharmacogenetics of alcoholism: a clinical neuroscience perspective.Differences between treatment-seeking and non-treatment-seeking participants in medication studies for alcoholism: do they matter?Functional significance of subjective response to alcohol across levels of alcohol exposure.Mechanisms of topiramate effects: refining medications development for alcoholism.
P50
Q27310644-3EBE85C6-5998-491A-9CF2-F0C499513187Q34070138-A307E25C-3C9D-4E92-BB7D-61E177492932Q34149087-EDE7A6EF-042A-4D7C-A6BA-F8CEC60E827DQ34213701-055D636F-418F-4D81-969C-5B59EDD0EAABQ34549370-A1E1275D-2781-4228-B1D6-4640D81B65C3Q35298102-7A2B47F9-4956-46BE-8481-CA408838E822Q35562848-D69D5B06-5467-4E4E-AB78-96782A85A358Q35689017-442B8D52-5F85-44AF-9D6D-37A7A348739BQ35815792-36187F83-59C3-47C1-BA96-002165645124Q36467926-D89CFB9F-EE09-43C5-8835-90BF70512F26Q36542339-BC685A65-B07B-4D61-819F-55E91915124CQ36931792-C900EE57-2230-4A9A-BE89-83AE83C33111Q37089324-61648880-7814-4413-96B9-DC9CB2DA04D6Q37712390-C5B3C06D-1960-48C0-BBEE-56F34A6C598FQ38685941-A56BDCD7-9666-4C69-AEC5-BFE8A0FE2B06Q38856407-83214E01-AFA7-4005-A47B-C8AA3FF44F47Q38860859-7E0AA31F-9389-4304-89C2-BE8AFFF8A944Q38867904-3D9CE310-AB19-4998-B887-0D08186D3318Q39076920-EC74E92B-E4E1-46A2-9E03-D8B65377CE0EQ39202591-BE4A39CF-EE71-4329-AC2F-6B0E731B9DEBQ39255477-A5AA0F7C-943A-413C-9643-59CFEF797034Q42157163-A0490B6E-4D03-49B5-A8E7-DD8301F29EBBQ46002465-3995B1AA-14B5-4730-A7EF-50CE9D448AA5Q46484038-173DA102-DC14-4FA8-BD68-4CC2B9F598DFQ46771116-A504CAF2-5F0C-4A02-81DE-46D932759DEC
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Spencer Bujarski
@en
Spencer Bujarski
@nl
type
label
Spencer Bujarski
@en
Spencer Bujarski
@nl
prefLabel
Spencer Bujarski
@en
Spencer Bujarski
@nl
P31
P496
0000-0002-2766-0696